Correction to: Experimental & Molecular Medicine https://doi.org/10.1038/s12276-023-01002-3, published online 01 June 2023
After the online publication of this article, the authors noticed an error in the Results section.
The correct statement of this article should have read as below.
In the original article, there was an error in Fig. 3d using a duplicate image of the same DMHF group as in a previous study conducted simultaneously with this study. There was no change in the morphology of DMHF in both the previous study and this study. However, this study explained the changes in morphology caused by the treatment of Empagliflozin and Sotagliflozin in the DMHF model based on previous research results. Therefore, the misuse of the image did not affect the results and scientific conclusions of the article. We would now like to replace Fig. 3d to provide a new, more representative Fig. 3 as follows:
The authors apologize for any inconvenience caused.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kim, I., Cho, HJ., Lim, S. et al. Author Correction: Comparison of the effects of empagliflozin and sotagliflozin on a zebrafish model of diabetic heart failure with reduced ejection fraction. Exp Mol Med 56, 250 (2024). https://doi.org/10.1038/s12276-023-01154-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s12276-023-01154-2
